Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model

Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model

Squamous cell carcinoma of oral cavity (OCSCC) accounts for approximately 25% of cases of head and neck squamous cell carcinoma (HNSCC). Tobacco and alcohol consumption are the main risk factors for both cancers. Surgical resection, combined with adjuvant radiotherapy or radiochemotherapy in patient...

Full description

Bibliographic Details
Main Authors: Vanesa Gutiérrez Calderón, Alexandra Cantero González, Laura Gálvez Carvajal, Yolanda Aguilar Lizarralde, Antonio Rueda Domínguez
Format: Article
Language:English
Published: SAGE Publishing 2021-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920984061

Internet

https://doi.org/10.1177/1758835920984061

Similar Items